You are here

Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
DRUG
CSE Index: 
Currency: 

Bright Minds is a pre-clinical biosciences company with a portfolio of compounds designed to precisely target abnormalities in neurocircuitry that lead to dysfunctional behaviors. Bright Minds is focused on developing targeted therapies with the potential to improve the treatment of mental health and neurological disorders through the use of serotonergic compounds leveraging its world class scientific and drug development expertise to bring forward the next generation of safe and efficacious neuropsychiatry drugs into the clinic. Bright Minds drugs extenuate the therapeutic aspects of psychedelic and other serotonergic compounds while minimizing the side effects thereby creating superior drugs to first generation compounds, such as psilocybin. Bright Minds was selected to participate in two National Institutes of Health (“NIH”) Programs. These NIH collaborations are evaluating Bright Minds serotonin agonists for therapeutic potential in pain and in epilepsy.

You are here

Bright Minds Biosciences Inc. (DRUG)

SEDAR Information

Company Info

Address
1500, 1055 West Georgia St.
Vancouver, BC V6E 4N7
Canada
Phone
647-407-2515
Email
ian@brightmindsbio.com
Website
https://brightmindsbio.com
Listing date
Monday, February 8, 2021
Transfer Agent
Computershare Investor Services Inc.

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
11,834,361
Reserved for Issuance: 
5,191,204

Company Officers

Ian McDonald, CEO
Revati Shreeniwas, Chief Medical Officer
Gideon Shapiro, Vice President (Discovery)
Ryan Cheung, Chief Financial Officer
Alan Kozikowski, Chief Scientific Officer and Director
Nils Bottler, Director
Jeremy Fryzuk, Director

Bulletins

05/02/2021

2021-0215 – New Listing - Bright Minds Biosciences Inc. (DRUG)

Le 5 février/February 2021

The common shares of Bright Minds Biosciences Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2021-12-09-Nation-Builder-of-the-Year-Award-2021_Website.jpg

2021 Nation Builder of the Year Award

Thursday, December 9, 2021 -
12:00pm to 1:00pm
JM_DigitalBanners_VRIC_Website.jpg

Vancouver Resource Investment Conference (VRIC)

Sunday, January 16, 2022 - 8:30am to Monday, January 17, 2022 - 5:30pm
Can-Securities-Exchange_PDAC22_web-740x374_Website.jpg

90th Annual PDAC Convention 2022

Monday, March 7, 2022 to Friday, March 11, 2022